Biomagnetics Diagnostics Corp. (USD) Biomagnetics Diagnostics Corp. operates as a pioneering company at the forefront of advanced medical device development and biotechnology. The firm's diagnostic technologies prioritize the direct, real-time detection of viruses, toxins, or the disease itself. This approach differs significantly from traditional methods that rely on identifying antibodies, which are part of the body's immune response and can take several weeks to many months to manifest. The company's product portfolio features the High Throughput Screening - Magnetic Testing Platform (HTS-MTP) and the Integrity Optical Biosensor (IOBS). The HTS-MTP system is designed to provide comprehensive analysis from a single test, offering both qualitative identification of chemical elements within a substance and precise quantitative measurements of specific components. Furthermore, its optical biosensor operates on the principle of protein-receptor binding. It utilizes planar optical waveguides to bring together two or more optically tagged receptors, thereby inducing changes in fluorescence that are almost instantly recognized by tiny, integrated detectors.

Biomagnetics Diagnostics Corp. (USD) Active

8864 Greenback Lane Suite EOrangevale, 95662United States, Orangevale, US

Stock Price USD

Price Change

Last Dividend USD

BMGP's stock peer is IXSBF (InNexus Biotechnology, Inc.)

BMGP's stock peer is NNLX (NanoLogix, Inc.)

BMGP's stock peer is OLMM (OneLife Technologies Corp.)

BMGP's stock peer is OZYMF (Strategic Partners A/S)

BMGP's stock peer is PXMD (PaxMedica, Inc. Common Stock)

BMGP's stock peer is SDCCQ (SmileDirectClub Inc Class A)

BMGP's stock peer is VAXX (Vaxxinity, Inc.)

BMGP's stock peer is WCUI (Wellness Center USA, Inc.)

BMGP's stock peer is XSNX (NovAccess Global Inc.)

Healthcare Medical - Specialties

Biomagnetics Diagnostics Corp. operates as a pioneering company at the forefront of advanced medical device development and biotechnology. The firm's diagnostic technologies prioritize the direct, real-time detection of viruses, toxins, or the disease itself. This approach differs significantly from traditional methods that rely on identifying antibodies, which are part of the body's immune response and can take several weeks to many months to manifest. The company's product portfolio features the High Throughput Screening - Magnetic Testing Platform (HTS-MTP) and the Integrity Optical Biosensor (IOBS). The HTS-MTP system is designed to provide comprehensive analysis from a single test, offering both qualitative identification of chemical elements within a substance and precise quantitative measurements of specific components. Furthermore, its optical biosensor operates on the principle of protein-receptor binding. It utilizes planar optical waveguides to bring together two or more optically tagged receptors, thereby inducing changes in fluorescence that are almost instantly recognized by tiny, integrated detectors.

Dividend Stats Yield is calculated via trailing-12-month period

Ex-Dividend	Payment Date	Dividend	Yield	Dividend Frequency
Dividend Data Not Exist

Disclaimers

StockQuay.com is not operated by a broker, dealer, or registered investment advisor. Under no circumstances should any information published on StockQuay.com be considered a recommendation to buy, sell, or hold any security. The content on this site and in its associated newsletters is intended solely for informational and educational purposes and does not constitute investment advice or financial recommendations.

Individuals or entities featured or referenced on StockQuay.com may engage in trading activity involving the securities mentioned in any article or report before or after such content is published. These individuals or entities are not affiliated with StockQuay.com, and their inclusion does not imply endorsement or accuracy of their views or actions.

StockQuay.com, its owners, or its affiliates shall not be held liable to any user or third party for any damages or losses arising from the use of content on this website. This includes, but is not limited to, investment losses, loss of profit, loss of data, missed opportunities, or indirect, incidental, or consequential damages.

Data is updated daily and is not guaranteed to be accurate or complete.

Past performance is not indicative of future results. Please conduct your own research or consult with a qualified financial advisor before making any investment decisions